Karl Wilkins

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Approach to the treatment of cutaneous malignancy in HIV-infected patients
    Karl Wilkins
    University of California, San Francisco, USA
    Dermatol Ther 18:77-86. 2005
  2. ncbi Cutaneous malignancy and human immunodeficiency virus disease
    Karl Wilkins
    Department of Dermatology, University of California San Francisco, California, USA
    J Am Acad Dermatol 54:189-206; quiz 207-10. 2006
  3. ncbi A dramatic change in HIV treatment
    Karl Wilkins
    Department of Dermatology, University of California-San Francisco, USA
    J Drugs Dermatol 3:452-5. 2004

Detail Information

Publications3

  1. ncbi Approach to the treatment of cutaneous malignancy in HIV-infected patients
    Karl Wilkins
    University of California, San Francisco, USA
    Dermatol Ther 18:77-86. 2005
    ..This article will review and discuss management issues for the following malignancies: lymphomas, malignant melanoma, basal cell carcinoma, squamous cell carcinoma, and Kaposi's sarcoma...
  2. ncbi Cutaneous malignancy and human immunodeficiency virus disease
    Karl Wilkins
    Department of Dermatology, University of California San Francisco, California, USA
    J Am Acad Dermatol 54:189-206; quiz 207-10. 2006
    ..LEARNING OBJECTIVE: At the completion of this learning activity, participants should be familiar with the unique epidemiology, clinical course, and management of cutaneous malignancy in patients infected with HIV...
  3. ncbi A dramatic change in HIV treatment
    Karl Wilkins
    Department of Dermatology, University of California-San Francisco, USA
    J Drugs Dermatol 3:452-5. 2004